Top Employee Participation Stories
FDA approves Eli Lilly's new weight loss drug Zepbound, cheaper than Wegovy
By Michael PopkeTirzepatide, the active ingredient in Lilly's new drug, is already approved under the trade name Mounjaro, a diabetes drug, but Zepbound will list for a lower pre-insurance price than Novo Nordisk's weight loss drug, Wegovy.










